author-photo

Holm Bussler

University of Rochester

29

Papers

277

Citations

Citation Trend

Filter By

Papers (24) Sort By

Journal Conference Others

Abstract PR10: Reprogramming myeloid cells in TME with pepinemab, first-in-class semaphorin 4D MAb, enhances combination immunotherapy

2019 Cancer immunology research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 1545: Altered myeloid and lymphoid composition of tumor microenvironment following anti-SEMA4D and immune checkpoint combination therapies

2019 Immunology
Show All
- Source
- Cite
- Save
Citations (1)
Abstract PR09: Breaking down barriers restricting myeloid cell differentiation and infiltration in the tumor microenvironment with a first-in-class antibody targeting semaphorin4D, and rational combination therapies

2018 Cancer immunology research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 1762: Shifting the tumor microenvironment with first-in-class semaphorin 4D mab for combination immunotherapy

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract B199: Targeting the tumor microenvironment with first-in-class Semaphorin4D MAb for combination immunotherapy

2018 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 3661: Breaking down the barrier restricting infiltration and differentiation of APC in the tumor microenvironment with a first-in-class antibody targeting Semaphorin4D, and rational combination therapies

2017 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract A119: Antibody blockade of Semaphorin 4D neutralizes barrier to immune infiltration and facilitates immune-mediated tumor rejection

2016 Cancer immunology research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract B023: Antibody blockade of Semaphorin 4D enhances infiltration of APC and CD8 T cells and reduces immune suppression to facilitate immune-mediated tumor rejection

2016 Cancer immunology research
Show All
- Source
- Cite
- Save
Citations (0)
Generation and preclinical characterization of an antibody specific for SEMA4D.

2016 mAbs
Show All
- Source
- Cite
- Save
Citations (22)
CXCL13 antibody for the treatment of autoimmune disorders

2015 BMC Immunology
Show All
- Source
- Cite
- Save
Citations (75)